CEACAM5 and gastric adenocarcinoma: The study conducted by Adrian Boicean showed that the performances of classical markers (CEA and CA 19-9) for predicting gastric adenocarcinoma were higher than the new marker miR-106, which emphasizes the important role of the biomarkers on the accuracy of GC detection [105].